KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Equity Average (2020 - 2025)

Organon (OGN) has 6 years of Equity Average data on record, last reported at $829.0 million in Q4 2025.

  • For Q4 2025, Equity Average rose 71.81% year-over-year to $829.0 million; the TTM value through Dec 2025 reached $829.0 million, up 71.81%, while the annual FY2025 figure was $612.0 million, 204.48% up from the prior year.
  • Equity Average reached $829.0 million in Q4 2025 per OGN's latest filing, up from $819.5 million in the prior quarter.
  • Across five years, Equity Average topped out at $5.1 billion in Q1 2021 and bottomed at -$1.8 billion in Q3 2021.
  • Average Equity Average over 5 years is -$8.8 million, with a median of -$170.2 million recorded in 2023.
  • Peak YoY movement for Equity Average: crashed 185.62% in 2022, then soared 4709.09% in 2025.
  • A 5-year view of Equity Average shows it stood at -$1.6 billion in 2021, then surged by 37.36% to -$979.0 million in 2022, then soared by 66.34% to -$329.5 million in 2023, then surged by 246.43% to $482.5 million in 2024, then surged by 71.81% to $829.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Average were $829.0 million in Q4 2025, $819.5 million in Q3 2025, and $637.5 million in Q2 2025.